vTv Therapeutics

+$0.01 (+0.51%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VTVT and other ETFs, options, and stocks.

About VTVT

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.

CEO
Stephen L. Holcombe
Employees
25
Headquarters
High Point, North Carolina
Founded
2015

VTVT Key Statistics

Market Cap
201.50M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
543.26K
High Today
$2.03
Low Today
$1.90
Open Price
$1.96
Volume
570.37K
52 Week High
$4.75
52 Week Low
$1.44

VTVT Earnings

-$0.11
-$0.07
-$0.02
$0.02
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure